|
TOP NEWS
LEGAL ETHICS & MALPRACTICE
REAL ESTATE & DEVELOPMENT
CONSUMER PROTECTION
INTELLECTUAL PROPERTY
HEALTHCARE & LIFE SCIENCES
Trade Group Latest To Sue Wash. Over 340B Drug Pricing Law
By Rachel Riley
Pharmaceutical Research and Manufacturers of America claims a new Washington state law attempts to illegally reshape the federal 340B Drug Pricing Program and singles out participating drugmakers with burdensome regulations, according to a fresh federal lawsuit that follows similar constitutional challenges mounted by Novartis and AbbVie.
2 documents attached |
Read full article »
| Save to favorites »
SECURITIES & WHITE COLLAR
COMPETITION
PRIVATE EQUITY
TELECOMMUNICATIONS
PEOPLE
EXPERT ANALYSIS
Keys To Building Defensible Psychedelic Therapy Programs
Given the rapidly evolving legal environment for psychedelic therapies and heightened liability and compliance risks facing providers, meticulous documentation, robust risk management protocols, and proactive engagement with professional organizations and insurers are essential strategies, say Kimberly Chew at Husch Blackwell and L. Alison McInnes at Mindful Health Solutions.
Read full article »
| Save to favorites »
LEGAL INDUSTRY
|